Skip to main content

Genitourinary

Protocols

Bladder

UGUAJNIV

Adjuvant Treatment of Resected Urothelial Carcinoma using Nivolumab


UGUAJNIV4

Adjuvant Treatment of Resected Urothelial Carcinoma using 4-Weekly Nivolumab


GUAJPG

Adjuvant therapy for urothelial carcinoma using CISplatin and gemcitabine


GUAVEV

Palliative Therapy for Urothelial Carcinoma using Enfortumab Vedotin


GUAVPEM

Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Using Pembrolizumab


GUAVPEM6

Treatment of Locally Advanced or Metastatic Urothelial Carcinoma Using 6-Weekly Pembrolizumab


GUAVPG

Palliative therapy for urothelial carcinoma using CISplatin and gemcitabine


GUBAVE

Maintenance Therapy of Locally Advanced or Metastatic Urothelial Carcinoma using Avelumab


GUBCG

Therapy for High or Intermediate Risk Non-Muscle Invasive Bladder Cancer using BCG


GUBCGIFN (deleted 01 Jan 2022)


GUBDDMVAC

Neoadjuvant Treatment of Urothelial Cancer using Dose-Dense Methotrexate, vinBLAStine, DOXOrubicin and CISplatin


GUBGEM

Intravesical Therapy for Non-Muscle Invasive Bladder Cancer using Gemcitabine


GUBGEMDOC

Intravesical Therapy for Non-Muscle Invasive Bladder Cancer Using Gemcitabine and Docetaxel


GUBMITO

Intravesical Therapy for Non-Muscle Invasive Bladder Cancer using Mitomycin


GUBPWRT

Treatment of Locally Advanced Bladder Cancer with Weekly CISplatin and Concurrent Radiation


GUMVAC

Therapy for transitional cell cancers of the urothelium using Methotrexate, vinBLAstine, DOXOrubicin and CISplatin


GUNAJPG

Neo-Adjuvant Therapy for Urothelial Carcinoma Using CISplatin and Gemcitabine

Top

Prostate

GUMCSPABI

Therapy for Metastatic Castration Sensitive Prostate Cancer using Abiraterone and predniSONE


GUMCSPAPA

Treatment of Metastatic Castration Sensitive Prostate Cancer using Apalutamide


GUMCSPENZ

Treatment for Metastatic Castration Sensitive Prostate Cancer using Enzalutamide


UGUNMPDAR

Non- Metastatic Castration Resistant Prostate Cancer Using Darolutamide


UGUNMPENZ

Therapy for Non-Metastatic Castration Resistant Prostate Cancer Using Enzalutamide


UGUPABI

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Abiraterone and predniSONE


UGUPAJABI

Therapy for Castration Sensitive Very High-Risk Non-Metastatic Prostate Cancer using Abiraterone and predniSONE


UGUPAPA

Treatment of Non- Metastatic Castration Resistant Prostate Cancer Using Apalutamide


GUPCABA

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Cabazitaxel and predniSONE


GUPDOC

Palliative Therapy for Metastatic Hormone Refractory Prostate Cancer Using DOCEtaxel and predniSONE


GUPDOCADT

First-Line Treatment of Castration Sensitive, Metastatic Prostate Cancer Using DOCEtaxel and Androgen Deprivation Therapy


UGUPENZ

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Enzalutamide


GUPHDBIC

Treatment of Prostate Cancer with High Dose Bicalutamide


GUPLHRH

Therapy for Prostate Cancer Using LHRH agonist (Goserelin, Leuprolide or Buserelin)


GUPLHRHA

Therapy for Advanced Prostate Cancer Using LHRH antagonist Degarelix


GUPMX

Palliative therapy for hormone-refractory prostate cancer using mitoXANTRONE and predniSONE


GUPNSAA

Non-Steroidal Treatment of Prostate Cancer


UGUPOLAP

Treatment of Metastatic Castration-Resistant Prostate Cancer using Olaparib


GUPRAD

Therapy for Metastatic Castration Resistant Prostate Cancer Using Radium-223

Top

Testicular

GUBEP

Curative Therapy for Germ Cell Cancer using Bleomycin, Etoposide and CISplatin


GUEP

Therapy for nonseminoma germ cell cancer using Etoposide-CISplatin


GUSCARB

Adjuvant therapy for stage I high risk seminoma using CARBOplatin


GUTAXGEM

Palliative therapy for germ cell cancers using PACLitaxel and gemcitabine


GUTIP

Therapy for Relapsed Testicular Germ Cell cancer using PACLitaxel, lfosfamide and CISplatin (TIP)


GUVEIP

Consolidation/ Salvage Treatment for Germ Cell Cancer Using VinBLAstine, CISplatin, Ifosfamide and Mesna


GUVIP2

Consolidation and Salvage Therapy for Nonseminoma Using Etoposide, CISplatin, Ifosfamide, Mesna

Top

Renal/Kidney

GUAJPEM

Adjuvant Treatment of Resected Renal Cell Carcinoma using Pembrolizumab


GUAJPEM6

Adjuvant Treatment of Resected Renal Cell Carcinoma using 6-Weekly Pembrolizumab


GUAVIPNI

Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Ipilimumab and Nivolumab


GUAVNIV

Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Nivolumab


GUAVNIV4

Treatment of Metastatic or Advanced Renal Cell Carcinoma Using 4-Weekly Nivolumab


GUAVPEMAX

Treatment of Metastatic Renal Cell Carcinoma Using Pembrolizumab and aXitinib


GUAVPEML

Treatment of Metastatic Renal Cell Carcinoma using Pembrolizumab and Lenvatinib


GUAVPEML6

Treatment of Metastatic Renal Cell Carcinoma using 6-weekly Pembrolizumab and Lenvatinib


GUAXIT

Therapy for Metastatic Renal Cell Carcinoma Using Axitinib


GUCABO

>Therapy for Metastatic Renal Cell Carcinoma Using Cabozantinib


GUEVER

Therapy for Advanced Renal Cancer Using Everolimus


GUPAZO

Palliative Therapy for Renal Cell Carcinoma Using Pazopanib


GUSORAF

Palliative Therapy for Renal Cell Carcinoma Using SORAfenib


GUSUNI

Palliative Therapy for Renal Cell Carcinoma Using SUNItinib


GUTEM

Therapy for Advanced Renal Cancer Using Temsirolimus

Top

Miscellaneous

GUAVD

Palliative Therapy for Advanced Adrenal Cortical Cancer Using DOXOrubicin


GUEDPM

Treatment of Metastatic Adrenocortical Cancer with Etoposide, DOXOrubicin, CISplatin and Mitotane


GUFUPRT

Combined Modality Therapy for Squamous Cell Cancer of the Genitourinary System Using Fluorouracil and CISplatin with Radiation


GUMITO

Treatment of Adrenal Cortical Cancer with Mitotane


GUSCPE

Palliative Therapy of Extensive Stage Genitourinary Small Cell Tumours with a Platinum and Etoposide


GUSCPERT

Therapy of Genitourinary Small Cell Tumours with a Platin and Etoposide with Radiation


Funding Algorithm

The funding algorithm provides information on what anti-cancer systemic therapy treatments are covered on the BC Cancer Benefit Drug List (formulary). It may not be a complete list of all treatment options that may be available and recommended by the treating physician.
Terms of use
The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

Use of these documents is at your own risk and is subject to BC Cancer's Terms of Use.


Tab Heading
SOURCE: Genitourinary ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority